Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease?

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 691-699

  Clark, Ian A ^a   Atwood, Craig S ^b,c,d  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; anxiety; cell cycle; dyotic signaling; endocrine dyscrasia; etanercept; inflammation; oxytocin; sex hormones; tumor necrosis factor (TNF)

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ESTRADIOL; ETANERCEPT; FOLLITROPIN; GONADORELIN; GONADOTROPIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUPRORELIN; LUTEINIZING HORMONE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYTOCIN; PROGESTERONE; SIGNAL PEPTIDE; TESTOSTERONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

AGGRESSION; AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANKYLOSING SPONDYLITIS; ANXIETY DISORDER; ARTICLE; CEREBROSPINAL FLUID; ENDOCRINE DYSCRASIA; HUMAN; HYPOTHALAMUS; INFLAMMATION; INFLAMMATORY CELL; NERVE DEGENERATION; NEUROENDOCRINE DISEASE; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; PERCEPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STROKE; TRAUMATIC BRAIN INJURY;

EID: 84455170771     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110887     Document Type: Article

References (127)

1. Bowen RL, Atwood CS (2004) Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 50, 265-290 (Pubitemid 39194344)
2. Atwood CS, Meethal SV, Liu T, Wilson AC, Gallego M, Smith MA, Bowen RL (2005) Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol 64, 93-103 (Pubitemid 40349307)
3. Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA (2009) Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimers disease. Neurochem Int 54, 84-88
4. Atwood CS, Bowen RL (2011) The reproductive-cell cycle theory of aging: An update. Exp Gerontol 46, 100-107
5. Wilson AC, Clemente L, Liu T, Bowen RL, Meethal SV, Atwood CS (2008) Reproductive hormones regulate the selective permeability of the blood-brain barrier. Biochim Biophys Acta 1782, 401-407
6. Arendt T, Holzer M, Gartner U, Bruckner MK (1998) Aberrancies in signal transduction and cell cycle related events in Alzheimers disease. J Neural Transm Supp 54, 147-158 (Pubitemid 28539351)
7. Raina AK, Monteiro MJ, McShea A, Smith MA (1999) The role of cell cycle-mediated events in Alzheimers disease. Int J Exp Pathol 80, 71-76 (Pubitemid 29197272)
8. Neve RL, McPhie DL, Chen Y (2000) Alzheimers disease: A dysfunction of the amyloid precursor protein(1). Brain Res 886, 54-66
9. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA (2000) Cyclin toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61, 128-133 (Pubitemid 30451799)
10. Herrup K, Neve R, Ackerman SL, Copani A (2004) Divide and die: Cell cycle events as triggers of nerve cell death. J Neurosci 24, 9232-9239 (Pubitemid 39426158)
11. Meethal SV, Smith MA, Bowen RL, Atwood CS (2005) The gonadotropin connection in Alzheimers disease. Endocrine 26, 317-326
12. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS (2004) Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 279, 20539-20545 (Pubitemid 38623501)
13. Casadesus G,Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, SmithMA(2006) Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 1762, 447-452 (Pubitemid 43344306)
14. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3×Tg-AD mice. J Neurosci 27, 13357-13365 (Pubitemid 350220504)
15. Lin J, Li X, Yuan F, Lin L, Cook CL, Rao Ch V, Lei Z (2010) Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 69, 253-261
16. Casadesus G, Milliken EL,Webber KM, Bowen RL, Lei Z, Rao CV, Perry G, Keri RA, Smith MA (2007) Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol 269, 107-111 (Pubitemid 46483837)
17. Barron AM, Verdile G, Taddei K, Bates KA, Martins RN (2010) Effect of chronic hCG administration on Alzheimers-related cognition and A beta accumulation in PS1KI mice. Endocrinol 151, 5380-5388
18. Frye CA, Duffy CK, Walf AA (2007) Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiol Learn Mem 88, 208-216 (Pubitemid 47223753)
19. Bryan KJ, Mudd JC, Richardson SL, Chang J, Lee HG, Zhu X, Smith MA, Casadesus G (2010) Down-regulation of serum gonadotropins is as effective as estrogen replace ment at improving menopause-associated cognitive deficits. J Neurochem 112, 870-881
20. Berry A, Tomidokoro Y, Ghiso J, Thornton J (2008) Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats. Horm Behav 54, 143-152
21. Bowen RL, Beaird H, Atwood CS, Smith MA, Rimm AA (2004) Men treated for prostate cancer have a decreased incidence of dementia. 9th International Congress on Alzheimers Disease, 17-22 July, Philadelphia, PA, USA
22. DAmicoAV, BraccioforteMH,Moran BJ, ChenMH(2010) Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease. Alzheimer Dis Assoc Disord 24, 85-89
23. Bowen RL, Isley JP, Atkinson RL (2000) An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12, 351-354 (Pubitemid 30156528)
24. Short RA, Bowen RL, OBrien PC, Graff Radford NR (2001) Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 76, 906-909 (Pubitemid 32825912)
25. Jaffe K, Blanco ME (1994) Involvement of amino acids, opioids, nitric oxide, and NMDA receptors in learning and memory consolidation in crickets. Pharmacol Biochem Behav 47, 493-496 (Pubitemid 24077715)
26. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4, 447-451 (Pubitemid 28212761)
27. Chang D, Kwan J, Timiras PS (1997) Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney cell line. Adv Exp Med Biol 429, 261-271 (Pubitemid 28011306)
28. Manthey D, Heck S, Engert S, Behl C (2001) Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 268, 4285-4291 (Pubitemid 32862889)
29. Petanceska SS, Nagy V, Frail D, Gandy S (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimers amyloid beta peptides in brain. Exp Gerontol 35, 1317-1325
30. Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, Lafrancois J, Simpkins J, Refolo LM, Petanceska S,Wang R, Duff K (2002) Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem 80, 191-196 (Pubitemid 34614591)
31. Gouras GK, Xu H, Gross RS, Greenfield JP, Hai B,Wang R, Greengard P (2000) Testosterone reduces neuronal secretion of Alzheimers beta-amyloid peptides. Proc Natl Acad Sci U S A 97, 1202-1205 (Pubitemid 30080836)
32. Pike CJ, Carroll JC, Rosario ER, BarronAM(2009) Protective actions of sex steroid hormones in Alzheimers disease. Front Neuroendocrinol 30, 239-258
33. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R (2000) Endogenous estrogen levels and Alzheimers disease among postmenopausal women. Neurology 54, 833-837 (Pubitemid 30111338)
34. Hogervorst E, BandelowS, Combrinck M, SmithAD(2004) Low free testosterone is an independent risk factor for Alzheimers disease. Exp Gerontol 39, 1633-1639 (Pubitemid 39576135)
35. WhartonW, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S. (2011) Shortterm hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimers disease: Results of a randomized controlled trial. J Alzheimers Dis 2011. Epub ahead of print]
36. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR (1999) Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimers disease: Results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24, 657-677 (Pubitemid 29277256)
37. Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR (2001) High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology 57, 605-612 (Pubitemid 32782986)
38. Fillit H,Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimers type. Psychoneuroendocrinology 11, 337-345 (Pubitemid 16002256)
39. Tan RS, Pu SJ (2003) A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimers disease. Aging Male 6, 13-17 (Pubitemid 36606396)
40. Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind MA, Craft S (2005) Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64, 2063-2068 (Pubitemid 40880994)
41. Porayette P, Gallego MJ, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS (2009) Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem 284, 23806-23817
42. Mak GK, Enwere EK, Gregg C, Pakarainen T, Poutanen M, Huhtaniemi I, Weiss S (2007) Male pheromone-stimulated neurogenesis in the adult female brain: Possible role in mating behavior. Nat Neurosci 10, 1003-1011 (Pubitemid 47185196)
43. Hawken PA, Jorre TJ, Rodger J, Esmaili T, Blache D, Martin GB (2009) Rapid induction of cell proliferation in the adult female ungulate brain (Ovis aries) associated with activation of the reproductive axis by exposure to unfamiliar males. Biol Reprod 80, 1146-1151
44. Haga S, Akai K, Ishii T (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 77, 569-575 (Pubitemid 19125369)
45. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24, 173-182 (Pubitemid 19271472)
46. Akiyama H, Kondo H, Mori H, Kametani F, Nishimura T, Ikeda K, Kato M, McGeer PL (1996) The aminoterminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimers disease patients. Neurosci Lett 219, 115-118 (Pubitemid 26396328)
47. Schenk D, Barbour R, DunnW, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C,Walker S,Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (Pubitemid 29327547)
48. Bishop GM, Robinson SR, Smith MA, Perry G, Atwood CS (2002) Call for Elan to publish Alzheimers trial details. Nature 416, 677 (Pubitemid 34429127)
49. Smith MA, Atwood CS, Joseph JA, Perry G (2002) Predicting the failure of amyloid-beta vaccine. Lancet 359, 1864-1865
50. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of Abeta42 immunisation in Alzheimers disease: Follow-up of a randomised, placebo-controlled phase I trial. Lancet 372, 216-223 (Pubitemid 351978111)
51. Atwood CS(2010) Amyloid-beta aggregation as a protective acute-phase response to injury/neurodegeneration:Abarrier function for amyloid-beta deposits. In:Functional Amyloid Aggregation , Rigacci S, BucciantiniM(Eds.), Research Signpost, Kerala, India, pp. 115-134
52. Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye Bouchaud N, Mariani J (1995) Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A 92, 3032-3035
53. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273, 27765-27767 (Pubitemid 28496060)
54. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC (1989) Interleukin regulates synthesis of amyloid beta-protein precursor mRNAin human endothelial cells. Proc Natl Acad Sci U S A 86, 7606-7610 (Pubitemid 19254505)
55. GeYW, LahiriDK(2002) Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimers disease. Ann N Y Acad Sci 973, 463-467 (Pubitemid 36125054)
56. Schmidt J, Barthel K, Wrede A, Salajegheh M, Bahr M, Dalakas MC (2008) Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 131, 1228-1240
57. Sommer G, Kralisch S, Lipfert J, Weise S, Krause K, Jessnitzer B, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2009) Amyloid precursor protein expression is induced by tumor necrosis factor alpha in 3T3-L1 adipocytes. J Cell Biochem 108, 1418-1422
58. Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS (2004) Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNKdependent MAPK pathway. J Biol Chem 279, 49523-49532 (Pubitemid 39625840)
59. GriffinWS,Stanley LC, Ling C, White L, MacLeodV, Perrot LJ, White CL, 3rd, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated inDownsyndrome and Alzheimer disease. Proc Natl Acad SciUS A 86, 7611-7615 (Pubitemid 19254506)
60. Tarkowski E, Andreasen N, Tarkowski A, Blennow K (2003) Intrathecal inflammation precedes development of Alzheimers disease. J Neurol Neurosurg Psych 74, 1200-1205
61. Laurin D, David Curb. J, Masaki KH, White LR, Launer LJ (2009) Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol Aging 30, 1724-1727
62. Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C (2009) Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 30, 1885-1889
63. Buchhave P, Zetterberg H, Blennow K, Minthon L, Janciauskiene S, Hansson O (2009) Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol Aging 450, 56-59
64. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, ZhangY,Wahlund LO,Westman E, KinseyA, Guntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, FoyC, OBrien D, Breen G, Furney SJ,Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L,Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimers disease. Arch Gen Psychiatry 67, 739-748
65. Hardardottir I, Kunitake ST, Moser AH, Doerrler WT, Rapp JH, Grunfeld C, Feingold KR (1994) Endotoxin and cytokines increase hepatic messengerRNAlevels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest 94, 1304-1309 (Pubitemid 24286476)
66. Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Zhu HQ, Zhang QQ, Zhang YD, Xu J (2011) Anti-TNFalpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res 1368, 239-247
67. Haider S, Knofler M (2009) Human tumour necrosis factor: Physiological and pathological roles in placenta and endometrium. Placenta 30, 111-123
68. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von ZastrowM, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNFalpha. Science 295, 2282-2285 (Pubitemid 34258846)
69. Bernardino L, Agasse F, Silva B, Ferreira R, Grade S, Malva JO (2008) Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 26, 2361-2371
70. Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M (2006) Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A 103, 14925-14930 (Pubitemid 44527830)
71. Kass AS, Lea TE, Torjesen PA, Gulseth HC, Forre OT (2010) The association of luteinizing hormone and folliclestimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: A case-control study. Scand J Rheumatol 39, 109-117
72. Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Baranao RI (2003) Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 18, 1767-1771 (Pubitemid 37107546)
73. Ferreira RA, Vieira CS, Rosa ESJC, Rosa e Silva AC, Nogueira AA, Ferriani RA (2010) Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: A comparative study with the GnRH analogue. Contraception 81, 117-122
74. Ficicioglu C, Kumbak B, Akcin O, Attar R, Yildirim G, Yesildaglar N (2010) Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols. Gynecol Endocrinol 26, 181-186
75. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, MasuzakiH(2010) Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod 25, 642-653
76. Shalaby MR, Waage A, Aarden L, Espevik T (1989) Endotoxin, tumor necrosis factor-a and interleukin-1 induce interleukin-6 production in vivo. Clin Immunol Immunopathol 53, 488-498 (Pubitemid 19284841)
77. Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN (1999) Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti- TNF-alpha therapy in rheumatoid arthritis. J Immunol 163, 1521-1528 (Pubitemid 29352775)
78. Mueller L, von Seggern L, Schumacher J, Goumas F, Wilms C, Braun F, BroeringDC(2010) TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts. Biochem Biophys Res Commun 397, 586-591
79. Redl H, Schlag G, Paul E, Bahrami S, BuurmanWA, Strieter RM, Kunkel SL, Davies J, Foulkes R (1996) Endogenous modulators of TNF and IL-1 response are under partial control of TNF in baboon bacteremia. Am J Physiol 40, R1193-R1198
80. Brennan FM, Chantry D, Jackson A, Maini R, FeldmannM (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244-247 (Pubitemid 19180612)
81. Ralston SH, Russell RG, GowenM(1990) Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausalwomen. J Bone Miner Res 5, 983-988 (Pubitemid 20307116)
82. Kipp M, Karakaya S, Johann S, Kampmann E, Mey J, Beyer C (2007) Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J Neuroendocrinol 19, 819-822 (Pubitemid 47386883)
83. Smith JA, Das A, Butler JT, Ray SK, Banik NL (2010) Estrogen or estrogen receptor agonist inhibits lipopolysaccharide-induced microglial activation and death. Neurochem Res 36, 1587-1593
84. Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R (1999) Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104, 503-513 (Pubitemid 29534334)
85. Hsu SM, Chen YC, Jiang MC (2000) 17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factorkappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells. Biochem Biophys Res Commun 279, 47-52
86. Jiang N, Chopp M, Stein D, Feit H (1996) Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735, 101-107 (Pubitemid 26336624)
87. Yang SH, Liu R, Wu SS, Simpkins JW (2003) The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann N Y Acad Sci 1007, 101-107 (Pubitemid 38253658)
88. SteinDG(2001) Brain damage, sex hormones and recovery: A new role for progesterone and estrogen? Trends Neurosci 24, 386-391 (Pubitemid 32938541)
89. Stein DG, Hoffman SW (2003) Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 6, 13-22 (Pubitemid 36626716)
90. Pan DS, Liu WG, Yang XF, Cao F (2007) Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed Environ Sci 20, 432-438 (Pubitemid 350247979)
91. Stein DG, Wright DW (2010) Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs 19, 847-857
92. Yi KD, Perez E, Yang S, Liu R, Covey DF, Simpkins JW (2010) The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res 1379, 61-70
93. Tarkowski E, LiljerothAM,Minthon L,Tarkowski A,Wallin A, Blennow K (2003) Cerebral pattern of pro- and antiinflammatory cytokines in dementias. Brain Res Bull 61, 255-260 (Pubitemid 36952471)
94. McNaull BB, Todd S, McGuinness B, Passmore AP (2010) Inflammation and anti-Inflammatory strategies for Alzheimers disease - a mini-review. Gerontology 56, 3-14
95. Gorlovoy P, Larionov S, Pham TT, Neumann H (2009) Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J 23, 2502-2513
96. Janelsins MC, Mastrangelo MA, Park KM, Sudol KL, Narrow WC, Oddo S, Laferla FM, Callahan LM, Federoff HJ, Bowers WJ (2008) Chronic neuron-specific tumor necrosis factor expression enhances the local inflammatory environment ultimately leading to neuronal death in 3×Tg-AD mice. Am J Pathol 173, 1768-1782
97. McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, TanseyMG(2009) Inhibition of soluble TNF signaling in a mouse model of Alzheimers disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis 34, 163-177
98. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5, 45
99. Tweedie D, Sambamurti K, Greig NH (2007) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Curr Alzheimer Res 4, 378-385 (Pubitemid 47421968)
100. van Gool WA, van de Beek D, Eikelenboom P (2010) Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet 375, 773-775
101. Medeiros R, Figueiredo CP, Pandolfo P, Duarte FS, Prediger RD, Passos GF, Calixto JB (2010) The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide. Behav Brain Res 209, 165-173
102. Clark IA, Alleva LM, Vissel B (2010) The roles of TNF in brain dysfunction and disease. Pharmacol Ther 128, 519-548
103. Carter CJ (2008) Interactions between the products of the Herpes simplex genome and Alzheimers disease susceptibility genes: Relevance to pathological-signalling cascades. Neurochem Int 52, 920-934
104. Tobinick EL, Chen K, Chen X (2009) Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging. BMC Res Note 2, 28
105. Mukherji M, Bell R, Supekova L,Wang Y, Orth AP, Batalov S, Miraglia L, Huesken D, Lange J, Martin C, Sahasrabudhe S, Reinhardt M, Natt F, Hall J, Mickanin C, Labow M, Chanda SK, Cho CY, Schultz PG (2006) Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci U S A 103, 14819-14824 (Pubitemid 44527812)
106. Di Bona D, Candore G, Franceschi C, Licastro F, Colonna Romano G, Camma C, Lio D, Caruso C (2009) Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimers disease. Brain Res Rev 61, 60-68
107. Vieira MM, Ferreira TB, Pacheco PA, Barros PO, Almeida CR, Araujo Lima CF, Silva Filho RG, Hygino J, Andrade RM, Linhares UC, Andrade AF, Bento CA (2010) Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol 229, 212-218
108. Suarez EC, Lewis JG, Kuhn C (2002) The relation of aggression, hostility, and anger to lipopolysaccharidestimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men. Brain Behav Immun 16, 675-684 (Pubitemid 36027058)
109. Patel A, Siegel A, Zalcman SS (2010) Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 24, 1276-1280
110. Uguz F, Akman C, Kucuksarac S, Tufekci O (2009) Antitumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 63, 50-55
111. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan W, Corthesy Theulaz I, Cherbut C, Bergonzelli GE, Collins SM (2010) Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139, 2102-2112
112. Andrews H, Barczak P, Allan RN (1987) Psychiatric illness in patients with inflammatory bowel disease. Gut 28, 1600-1604 (Pubitemid 18033067)
113. Rodriguez-Sierra JF, HagleyMT, Hendricks SE (1986) Anxiolytic effects of progesterone are sexually dimorphic. Life Sci 38, 1841-1845 (Pubitemid 16068744)
114. Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, Neumann ID (2008) Oxytocin reduces anxiety via ERK1/2 activation: Local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27, 1947-1956 (Pubitemid 351521499)
115. Missig G, Ayers LW, Schulkin J, Rosen JB (2010) Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacol 35, 2607-2616
116. Slattery DA, Neumann ID (2010) Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacol 58, 56-61
117. Lee R, Ferris C, Van de Kar LD, Coccaro EF (2009) Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinol 34, 1567-1573
118. Clodi M,Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A (2008) Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol 295, E686-E691
119. Norman GJ, Karelina K, Morris JS, Zhang N, Cochran M, Courtney DeVries A (2010) Social interaction prevents the development of depressive-like behavior post nerve injury in mice: A potential role for oxytocin. Psychosom Med 72, 519-526
120. Huang HJ, Liang KC, Ke HC, Chang YY, Hsieh Li HM (2011) Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice. Brain Res 2011, 150-160
121. Karelina K, Norman GJ, Zhang N, Morris JS, Peng H, DeVries AC (2009) Social isolation alters neuroinflammatory response to stroke. Proc Natl Acad Sci U S A 106, 5895-5900
122. Tobinick EL, Gross H,Weinberger A, CohenH(2006) TNFalpha modulation for treatment of Alzheimers disease: A 6- month pilot study. MedGenMed Neurol Neurosur 8, 25
123. Tobinick EL, Gross H (2008) Rapid cognitive improvement in Alzheimers disease following perispinal etanercept administration. J Neuroinflamm 5, 2
124. Chio CC, Lin JW, Chang MW, Wang CC, Yang CZ, Chang CP (2010) Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem 115, 921-929
125. Tobinick E (2011) Rapid improvement of chronic stroke deficits after perispinal etanercept: Three consecutive cases. CNS Drugs 25, 145-155
126. Dinomais M, Stana L, Egon G, Richard I, Menei P (2009) Significant recovery of motor function in a patient with complete T7 paraplegia receiving etanercept. J Rehabil Med 41, 286-288
127. Qin LY, Wu XF, Block ML, Liu YX, Bresse GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462 (Pubitemid 46383175)